America’s fisheries are among the world’s richest in abundance and diversity. They provide scientific, aesthetic, recreational, commercial, subsistence, cultural, social, and economic benefits. FAC leads aquatic resource management for the Service and strives to invest its resources in the nation’s highest priority aquatic conservation and water-based recreational needs. Fish health is a critical component of healthy fisheries and core to the work of the Fish and Aquatic Conservation Program.
The Aquatic Animal Drug Approval Partnership (AADAP) program is part of the Fish and Aquatic Conservation fish health work. It is the only program in the United States singularly dedicated to obtaining U.S. Food and Drug Administration (FDA) approval of new medications needed for use in fish culture and fisheries management. Since the late 1990’s, AADAP has contributed to virtually every new fish medication approved by the FDA. Ultimately, the AADAP program allows fisheries professionals to more effectively and efficiently rear and manage a variety of fish species to meet production goals, stock healthy fish, and maintain a healthy environment.
Do you wish there was a webpage you could visit to answer any INAD questions that you may have? Can't remember how to add another fish species to your investigator account or even what is needed to get started with the INAD Program? Well, now you're in luck as AADAP has compiled the most common INAD questions that we've received and posted the answers to our new INAD U webpage!
Please visit INAD U for information that includes: how to add enrollment to your investigator account; how to change out an investigator or monitor; adding receipt of drug to the inventory page; and many more fascinating INAD topics. We hope to keep adding to this webpage with more how-to videos and additional INAD reference guides. Be sure to mark this webpage as a favorite as it is sure to be your go-to page whenever you have questions about the INAD Program.
Calling all Aquaculture America 2021 attendees! Are you interested in speaking in a special session at Aquaculture America 2021, to be held in San Antonio, Texas from August 11-14th, 2021. Please follow the link below to learn more about the National Aquaculture Association (NAA) special sessions that AADAP is co-hosting with the Aquatic Drug Approval Coalition (ADAC) and the Association of Fish and Wildlife Agencies-Drug Approval Working Group (AFWA-DAWG).
The National Aquaculture Association (NAA) and the Food and Drug Administration’s Center for Veterinary Medicine (FDA-CVM) began discussions on the opportunity to allow indexing of drugs for non-food life stages of food species where there was a reasonable certainty that the treated animal would not be used as human food, nor fed to another food-producing animal. Beyond early life stages, broodstock were identified as a group that currently meet, or could meet these criteria if indexing was available. The NAA and FDA-CVM developed a national survey that was intended to identify aquaculture species, potential compounds that might be used, number of animals involved, practices to delineate broodstock from other animals on the farm, and whether broodstock ever entered the human food chain. The survey also included questions about extension and outreach, and other permits, certifications, or regulations that might reinforce an index label.
AADAP's Quick Desk Reference Guide to Approved Drugs for Use in Aquaculture has been updated with the newest indications! This guide is an easy to use resource that outlines which aquaculture drugs are approved by FDA and what they can be used for. Additionally, it contains examples for calculating the amount of each drug to use for a particular situation. You can download the latest version of AADAP's Quick Desk Reference Guide to Approved Drugs for Use in Aquaculture (updated July 2020) from the Resources webpage. Hard copies of the updated Quick Desk Reference Guide will be available once all AADAP staff have returned to the the office.